High-risk psychotropic and high chronic disease management use

High-risk psychotropic and high chronic disease management use has been studied in 1 paper since 2026: 1 observational study in people; 1 in the past year. The newest story, Nov 4, 2026: “High-risk drug use linked to higher death risk in dementia”.

Exposure

1 paper studies it1 findingUpdated Sep 22, 2026

1 new paper in 30 daysSee all 1 papers on high-risk psychotropic and high chronic disease management use

At a glance

The findings reach people, from one lab or study. 1 lab.

“Clusters with a high prevalence of high-risk psychotropic use were consistently associated with higher mortality.”

Clusters of Health Service and Psychotropic Use and Mortality Risk in People With Dementia: An Australian Cohort StudyJournal of the American Medical Directors Association2026doi:10.1016/j.jamda.2026.106502

1 lab

Humans1

What is high-risk psychotropic and high chronic disease management use linked with?

Studies link high-risk psychotropic and high chronic disease management use with 1 measure, most often mortality (1 study).

Mortality

upin humans1

1 study

High-risk psychotropic and high chronic disease management use is associated with mortality in humans (People with dementia; inverse probability of treatment weighting adjustment) (aHR 1.27, 95% CI 1.21–1.34).
“Clusters with a high prevalence of high-risk psychotropic use were consistently associated with higher mortality.”
HumansPeople with dementia; inverse probability of treatment weighting adjustment12 monthsn = 165,655
High-risk drug use linked to higher death risk in dementia
Journal of the American Medical Directors AssociationSep 22, 2026

Latest

1 paper in 12 months

Journal of the American Medical Directors AssociationNov 4

High-risk drug use linked to higher death risk in dementia

Two groups with high-risk psychiatric medicine use had adjusted hazard ratios for death of 1.27 and 1.35 versus the reference group over 12 months.Two groups with high-risk psychiatric medicine use had adjusted hazard ratios for death of 1.27 and 1.35 versus the reference group over 12 months.

Cohort · 165,655 peopleDementia

Paper